Janssen Submits Esketamine Nasal Spray New Drug Application to U.S. FDA for Treatment-Resistant Depression

September 04, 2018 The Janssen Pharmaceutical Companies of Johnson& Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for esketamine nasal spray. Janssen is seeking...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news